Oversea-Chinese Banking Corp (OCBC)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
14,192
+9,309
+191% +$751K 0.02% 246
2026
Q1
$423K Buy
+4,883
New +$468K 0.01% 285
2023
Q4
– Sell
-58,410
Closed -$4.58M – 369
2023
Q3
$4.58M Buy
58,410
+2,831
+5% +$237K 0.21% 85
2023
Q2
$4.9M Hold
55,579
– – 0.23% 77
2023
Q1
$4.48M Hold
55,579
– – 0.22% 83
2022
Q4
$4.32M Buy
+55,579
New +$4.5M 0.25% 77

Other funds holding MDT

Oversea-Chinese Banking Corp (OCBC)'s MDT Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) increased its Medtronic (MDT) stake by 191% in Q2 2026, buying an estimated $751K and bringing the position to 14,192 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #246.

Oversea-Chinese Banking Corp (OCBC) first reported a position in MDT in Q4 2022 and has held it in 6 quarters since. The position peaked at $4.9M in Q2 2023. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 14,192 shares of Medtronic worth $1.12M as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) bought 9,309 Medtronic shares in Q2 2026, an estimated $751K.
  • Medtronic made up 0.02% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #246 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Medtronic in Q4 2022 and has held it in 6 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s Medtronic position peaked at $4.9M in Q2 2023.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.